BIOMARKERS
Biomarkers for Thyroid cancer
1. TG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. RET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. NTRK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. CALCB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. BRAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. NKX2-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. TP53
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. ATM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. RHOH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ER
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. CEACAM5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. AKT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. ESR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. MAPK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. PTEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. ELN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. EGFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. PR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. PIK3CA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MYC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CCDC6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. HRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. BCL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. PAX8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. Ki-67
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. ERBB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. PTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FBXW7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. TSHR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. APC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. NRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FANCA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. AR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. NCOA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. KRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. POLE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. CTLA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. CDKN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. TP63
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. FGFR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. FAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. KDR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. MUC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. MTOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. GNAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MS4A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. SRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MAX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. RB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. CDKN1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. JUN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. ITK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. TIMP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. SPEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. ENO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. SDHB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. NCOR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. IL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. CgA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. RARA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. PRKAR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. ROS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. ABL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. MEN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. MUC16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. ABL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. FUS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. STAT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. PSA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. TERT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. DDIT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. MET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. PTPRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. VHL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. HIF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. BRCA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. SDHD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. BCR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. GOPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. RAF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PPARG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. uPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. CDX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MLH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. NR4A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. POU5F1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. MDM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MAP2K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. EWSR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. LDH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. SERPINE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. EP300
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. STK11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. AFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. CALR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. HMGA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. CD79A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. CXCR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. PDGFRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. NCOR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. SDHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. FOXP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CDC73
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. CDKN2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. NF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. SMAD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. CREBBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. MSH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. PRF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. HSP90AA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. IDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MYCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. WT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. BRCA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. NF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. Beta-hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. BLM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. ERBB3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. SMAD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. TRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. YWHAE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. ABCG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. BRD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. NOTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. RHOA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. SDHC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. CDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. CDK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. CTNNB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. KMT2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NCKIPSD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CCND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CHEK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. FH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FHIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. ARID1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. DICER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. FLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. IGH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. ETV6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. IDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. NTRK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. RAC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. TNFRSF14
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. EML4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. NFE2L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. SMAD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. TFG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PDCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CUX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FGFR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. FLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. EZH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. FOXO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. HMGA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. TPR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. HER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. ERBB4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. KLK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. PPFIBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. SS18
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. SSX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. STIL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. TAF15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. AKAP9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. AKT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. CDK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. MALT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. PICALM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PML
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. SOX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. TAL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. TSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. FLCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. FOXA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. HLA-A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. MDM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. MUTYH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. PDGFRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. TPM3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. TSC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. ZNF331
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. AXIN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. BIRC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. COL1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. EBF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. ERC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. EXT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. FANCD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. FGFR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. MYB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. PTPN11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ARNT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. CANT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. CRTC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. ERCC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. ERG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. GATA3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. JAK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. SDHAF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. SMO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. TMEM127
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CD274
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. CDH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. CLIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. CYLD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. FOXO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. GOLGA5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. MAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. MLLT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. NPM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. NRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. NT5C2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. PDGFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. PLCG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. TMPRSS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ATR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. BUB1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CBL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CCND2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CD74
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. FES
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. FLI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. FUBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. KIF5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. PAX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. PRCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. REL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. RUNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. SMARCB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TFE3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. TRIM33
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. ATRX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. ERCC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. FEV
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. FGFR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. GNAQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. HEY1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. IGL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. IL6ST
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. IL7R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. LMNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. MAML2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. MSH6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. MSN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. MYD88
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. NBN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. NUTM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. SALL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SLC34A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. SOCS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. SSX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. STAT5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. TBL1XR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. TRIM24
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. TRIM27
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. TRIP11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. U2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. USP6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. WAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. ZBTB16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. ZNF198
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. TOP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. Neurokinin
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. ARID1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. BAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. BCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. BCL9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. BMPR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. CHIC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ERCC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. EZR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. FANCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. FGFR1OP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. FOXP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. GPC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. HOXA9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. KEAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. KLF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. KLF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. LPP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. MALAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. MYOD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. NCOA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. NDRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PMS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. RALGDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. RECQL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. SMARCA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. STRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. TCF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. TFRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. THRAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. TNFAIP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. TNFRSF17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. TRRAP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. CYP2D6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. WFDC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. CD52
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. ACVR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. AXIN2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. B2M
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. BCOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. BTK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. CAMTA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. CASP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. CEBPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. CIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. CREB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. CREB3L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. DAXX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. DDX6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. EIF4A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. ELF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. ERCC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. ETV1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. ETV5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. FOXL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. HNF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. HOOK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. JAK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. KCNJ5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. LRP1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. MAP2K2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. MAP3K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. MITF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. MLLT11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. MYCL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. NCOA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. NONO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. OLIG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. PCM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. PCSK7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. PIM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. PLAG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. PMS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. POT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. PRKACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. PTK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. PTPN13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. SEPT5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. SPECC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. SSX4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. TET1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. TFEB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. TLX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. TRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. TRD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. WRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. WWTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. SET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. ACVR2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. ALDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. ARHGAP26
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. ATF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. ATP1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. BCL11A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. BCL11B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. BCL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. BTG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. CARD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. CARS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. CCNE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. CDK12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. CNBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. COL2A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. CTCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. DDR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. DNMT3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. DROSHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. ELK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. EPAS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. EXT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. FCGR2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. FOXO4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. GATA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. GATA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. HIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. HNRNPA2B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. HOXD13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. IGK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. IRF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. KTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. LASP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. LCK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. LIFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. MAP2K4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. MKL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. MLLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. MYH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. NFKB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. NIN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. NOTCH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. NSD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. OMD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. PALB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. PHOX2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. PPM1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. PPP6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. PRDM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. PRRX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. PTPRT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. RANBP2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. RPL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. RSPO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. RSPO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. SEPT9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. SETD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. SPOP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. TCF7L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. TGFBR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. TPM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. UBR5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. XPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. XPO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. CEP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. MK167
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. FANCE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. ABI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. ACKR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. ACSL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. ACSL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. AFF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. AFF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. AFF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. AMER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. APOBEC3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. ARHGEF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. ARID2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. ASPSCR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. ASXL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. ATIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. ATP2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. BCL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. BCL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. BCL7A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. BCL9L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. BCORL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. BRD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. BRIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. C12orf9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. C15orf65
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. C2orf44
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. CACNA1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. CASC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. CBFA2T3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. CBFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. CBLB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. CBLC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. CCNB1IP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. CCND3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. CD79B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. CEP89
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. CHCHD7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. CHD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. CIITA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. CLP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. CLTC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. CLTCL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. CNOT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. CNTRL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. COX6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. CREB3L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. CRLF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. CRTC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. CSF3R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. DCTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. DDB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. DDX10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. DDX3X
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. DDX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. DEK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. DNAJB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. DNM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. DUX4L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. ECT2L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. EIF3E
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. ELL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. EPS15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. ETNK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. ETV4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. FAM131B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. FAM46C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. FANCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. FANCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. FAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. FAT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. FBXO11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. FCRL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. FIP1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. FNBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. FSTL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. GAS7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. GMPS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. GNA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. GPHN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. GRIN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. H3F3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. H3F3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. HERPUD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. HIST1H3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. HIST1H4I
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. HLF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. HMGN2P46
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. HOXA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. HOXA13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. HOXC11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. HOXC13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. HOXD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. HSP90AB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. IKBKB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. IKZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. IL21R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. JAK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. JAZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. KAT6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. KAT6B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. KDM5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. KDM5C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. KDM6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. KDSR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. KIAA1549
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. KIAA1598
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. KMT2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. KMT2D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. LCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. LEF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. LHFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. LMO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. LMO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. LRIG3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. LSM14A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. LYL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. LZTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. MAFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. MAP3K13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. MDS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. MECOM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. MED12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. MLF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. MLLT10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. MLLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. MLLT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. MN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. MNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. MPL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. MSI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. MTCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. MYH9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. MYO5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. NAB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. NACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. NFATC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. NFIB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. NFKBIE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. NUMA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. NUP214
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. NUP98
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. NUTM2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. NUTM2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. P2RY8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. PAFAH1B2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. PAX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. PAX7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. PBRM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. PBX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. PDCD1LG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. PDE4DIP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. PER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. PHF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. PIK3R1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. POU2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. PPP2R1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. PRDM16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. PREX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. PSIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. PTPRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. PTPRK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. PWWP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. QKI
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. RABEP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. RAD21
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. RAD51B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. RANBP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. RAP1GDS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. RBM10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. RBM15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. RMI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. RNF213
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. RNF217-AS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. RNF43
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. RPL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. RPL22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. RPN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. RUNDC2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. RUNX1T1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. SBDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. SDC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. SEPT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. SETBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. SF3B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. SFPQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. SFRP4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. SH2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. SH3GL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. SLC45A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. SMARCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. SMARCE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. SND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. SRGAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. SRSF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. SRSF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. SS18L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. STAG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. STAT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. SUFU
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. SUZ12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. SYK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. TAL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. TBX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. TCEA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. TCF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. TCL1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. TCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. TET2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TFPT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TLX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TOP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TRAF7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TTL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. USP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. VTI1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. WHSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. WHSC1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. WIF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. XPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. ZCCHC8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. ZFHX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZNF278
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF384
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZNF521
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZRSR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. Nuclear matrix protein 22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. PAM50
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]